A detailed history of Addison Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Addison Advisors LLC holds 2,707 shares of NVO stock, worth $287,293. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,707
Previous 2,750 1.56%
Holding current value
$287,293
Previous $392,000 17.86%
% of portfolio
0.09%
Previous 0.13%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$119.07 - $145.42 $5,120 - $6,253
-43 Reduced 1.56%
2,707 $322,000
Q2 2024

Aug 05, 2024

BUY
$122.71 - $146.91 $40,739 - $48,774
332 Added 13.73%
2,750 $392,000
Q1 2024

May 06, 2024

BUY
$102.11 - $135.92 $8,883 - $11,825
87 Added 3.73%
2,418 $310,000
Q4 2023

Feb 02, 2024

BUY
$87.78 - $105.45 $22,383 - $26,889
255 Added 12.28%
2,331 $241,000
Q3 2023

Nov 07, 2023

BUY
$90.94 - $199.54 $64,840 - $142,272
713 Added 52.31%
2,076 $188,000
Q2 2023

Aug 03, 2023

BUY
$155.98 - $172.65 $4,367 - $4,834
28 Added 2.1%
1,363 $220,000
Q1 2023

May 09, 2023

SELL
$132.34 - $159.14 $2,911 - $3,501
-22 Reduced 1.62%
1,335 $212,000
Q4 2022

Feb 07, 2023

SELL
$102.55 - $135.33 $41,737 - $55,079
-407 Reduced 23.07%
1,357 $183,000
Q3 2022

Oct 28, 2022

BUY
$95.28 - $116.93 $1,715 - $2,104
18 Added 1.03%
1,764 $176,000
Q2 2022

Aug 04, 2022

SELL
$103.24 - $121.81 $20,028 - $23,631
-194 Reduced 10.0%
1,746 $195,000
Q1 2022

Apr 29, 2022

BUY
$93.1 - $112.54 $61,259 - $74,051
658 Added 51.33%
1,940 $215,000
Q4 2021

Jan 31, 2022

BUY
$95.88 - $117.08 $121,959 - $148,925
1,272 Added 12720.0%
1,282 $144,000
Q3 2021

Nov 08, 2021

BUY
$84.42 - $106.62 $844 - $1,066
10 New
10 $1,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $240B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Addison Advisors LLC Portfolio

Follow Addison Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Addison Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Addison Advisors LLC with notifications on news.